Effects of Rosiglitazone and Alpha-lipoic Acid on the Patients With Pathologically Proved NASH

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
This study is to evaluate the effects of Rosiglitazone, insulin sensitizer and alpha-lipoic acid, antioxidant on patients with pathologically proved NASH (non-alcoholic steato-hepatitis).
Epistemonikos ID: 5e47d06471be3802d01498431db97386b57de5f3
First added on: May 06, 2024